Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer.

about

Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer.

Item

http://www.wikidata.org/entity/Q38670254

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Comparative Toxicity and Effec ...... ith Early-Stage Breast Cancer.

@en

type

Item

label

Comparative Toxicity and Effec ...... ith Early-Stage Breast Cancer.

@en

prefLabel

Comparative Toxicity and Effec ...... ith Early-Stage Breast Cancer.

@en

P1476

Comparative Toxicity and Effec ...... With Early-Stage Breast Cancer

@en

P2093

Anne Marie Meyer

http://www.w3.org/2001/XMLSchema#string

Katherine E Reeder-Hayes

http://www.w3.org/2001/XMLSchema#string

Ke Meng

http://www.w3.org/2001/XMLSchema#string

Lisa A Carey

http://www.w3.org/2001/XMLSchema#string

Sharon Peacock Hinton

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

A modified poisson regression approach to prospective studies with binary data

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

Adjuvant trastuzumab in HER2-positive breast cancer.

P304

3298-3305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2016.71.4345

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stacie B. Dusetzina

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28727517

http://www.w3.org/2001/XMLSchema#string

P932

5652869

http://www.w3.org/2001/XMLSchema#string